Faron Pharmaceuticals Oy (FARN.L)
GBp 175.0
(2.94%)
GBp 175.0
(2.94%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 25.38 Million EUR | 11.58% |
| 2022 | 22.74 Million EUR | 121.62% |
| 2021 | 10.26 Million EUR | 0.47% |
| 2020 | 10.21 Million EUR | 18.8% |
| 2019 | 8.59 Million EUR | 12.66% |
| 2018 | 7.63 Million EUR | -24.75% |
| 2017 | 10.14 Million EUR | 58.4% |
| 2016 | 6.4 Million EUR | 75.79% |
| 2015 | 3.64 Million EUR | 8.65% |
| 2014 | 3.35 Million EUR | 5.24% |
| 2013 | 3.18 Million EUR | 14.89% |
| 2012 | 2.77 Million EUR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 34.08 Million EUR | 34.28% |
| 2024 Q2 | 34.08 Million EUR | 0.0% |
| 2023 Q2 | 22.32 Million EUR | 0.0% |
| 2023 Q1 | 22.31 Million EUR | -1.88% |
| 2023 Q3 | 25.38 Million EUR | 13.71% |
| 2023 Q4 | 25.38 Million EUR | 0.0% |
| 2023 FY | 25.38 Million EUR | 11.58% |
| 2022 Q1 | 21.92 Million EUR | 113.59% |
| 2022 Q3 | 22.74 Million EUR | 3.76% |
| 2022 FY | 22.74 Million EUR | 121.62% |
| 2022 Q4 | 22.74 Million EUR | 0.0% |
| 2022 Q2 | 21.92 Million EUR | 0.0% |
| 2021 Q3 | 10.26 Million EUR | 13.37% |
| 2021 Q2 | 9.05 Million EUR | 0.01% |
| 2021 Q1 | 9.05 Million EUR | -11.39% |
| 2021 FY | 10.26 Million EUR | 0.47% |
| 2021 Q4 | 10.26 Million EUR | 0.01% |
| 2020 Q3 | 10.21 Million EUR | 45.32% |
| 2020 FY | 10.21 Million EUR | 18.8% |
| 2020 Q4 | 10.21 Million EUR | 0.0% |
| 2020 Q2 | 7.03 Million EUR | 0.0% |
| 2020 Q1 | 7.03 Million EUR | -18.25% |
| 2019 Q4 | 8.59 Million EUR | 0.0% |
| 2019 FY | 8.59 Million EUR | 12.66% |
| 2019 Q1 | 6.86 Million EUR | -10.09% |
| 2019 Q2 | 6.86 Million EUR | 0.0% |
| 2019 Q3 | 8.59 Million EUR | 25.3% |
| 2018 FY | 7.63 Million EUR | -24.75% |
| 2018 Q3 | 7.63 Million EUR | -23.63% |
| 2018 Q1 | 9.99 Million EUR | -1.48% |
| 2018 Q2 | 9.99 Million EUR | 0.01% |
| 2018 Q4 | 7.63 Million EUR | 0.0% |
| 2017 Q1 | 6.6 Million EUR | 3.15% |
| 2017 Q4 | 10.14 Million EUR | 0.0% |
| 2017 Q3 | 10.14 Million EUR | 53.58% |
| 2017 Q2 | 6.6 Million EUR | 0.0% |
| 2017 FY | 10.14 Million EUR | 58.4% |
| 2016 Q3 | 7.34 Million EUR | 17.25% |
| 2016 FY | 6.4 Million EUR | 75.79% |
| 2016 Q1 | 6.26 Million EUR | 71.97% |
| 2016 Q2 | 6.26 Million EUR | 0.0% |
| 2016 Q4 | 6.4 Million EUR | -12.84% |
| 2015 Q2 | 3.32 Million EUR | 0.0% |
| 2015 Q4 | 3.64 Million EUR | 0.0% |
| 2015 Q3 | 3.64 Million EUR | 9.66% |
| 2015 Q1 | 3.32 Million EUR | -0.92% |
| 2015 FY | 3.64 Million EUR | 8.65% |
| 2014 FY | 3.35 Million EUR | 5.24% |
| 2014 Q1 | - EUR | 0.0% |
| 2014 Q3 | 3.35 Million EUR | 0.0% |
| 2014 Q4 | 3.35 Million EUR | 0.0% |
| 2013 FY | 3.18 Million EUR | 14.89% |
| 2012 FY | 2.77 Million EUR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|